RFC1 repeat expansions: A recurrent cause of sensory and autonomic neuropathy with cough and ataxia.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
07 2022
Historique:
revised: 20 02 2022
received: 19 01 2022
accepted: 26 02 2022
pubmed: 8 3 2022
medline: 15 6 2022
entrez: 7 3 2022
Statut: ppublish

Résumé

Ataxia and cough are rare features in hereditary sensory and autonomic neuropathies (HSAN), a group of diseases of mostly unknown genetic cause. Biallelic repeat expansions in RFC1 are associated with cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS). This study aimed to investigate the prevalence of RFC1 repeat expansions in a cohort of HSAN patients. After unremarkable whole-exome sequencing (WES) analysis, we performed repeat-primed PCR to detect intronic RFC1 expansions in 12 HSAN families, who all presented with chronic cough. In these patients, 75% carried biallelic expansions of the pathogenic AAGGG motif. Compared with RFC1-/- cases, RFC1+/+ cases presented more consistently with positive sensory and autonomic symptoms. Afferent ataxia was more severe in the RFC1+/+ cohort and cerebellar ataxia was a common feature (21%). We demonstrate that RFC1 is a frequent cause of (WES-negative) HSAN with chronic cough and ataxia. The diagnostic yield of RFC1 repeat-primed PCR was surprisingly high, given that HSAN is genetically poorly understood. This combination of HSAN, ataxia, and chronic cough symptoms represents a new nosological entity within the neuropathy-ataxia spectrum.

Sections du résumé

BACKGROUND AND PURPOSE
Ataxia and cough are rare features in hereditary sensory and autonomic neuropathies (HSAN), a group of diseases of mostly unknown genetic cause. Biallelic repeat expansions in RFC1 are associated with cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS). This study aimed to investigate the prevalence of RFC1 repeat expansions in a cohort of HSAN patients.
METHODS
After unremarkable whole-exome sequencing (WES) analysis, we performed repeat-primed PCR to detect intronic RFC1 expansions in 12 HSAN families, who all presented with chronic cough.
RESULTS
In these patients, 75% carried biallelic expansions of the pathogenic AAGGG motif. Compared with RFC1-/- cases, RFC1+/+ cases presented more consistently with positive sensory and autonomic symptoms. Afferent ataxia was more severe in the RFC1+/+ cohort and cerebellar ataxia was a common feature (21%).
CONCLUSIONS
We demonstrate that RFC1 is a frequent cause of (WES-negative) HSAN with chronic cough and ataxia. The diagnostic yield of RFC1 repeat-primed PCR was surprisingly high, given that HSAN is genetically poorly understood. This combination of HSAN, ataxia, and chronic cough symptoms represents a new nosological entity within the neuropathy-ataxia spectrum.

Identifiants

pubmed: 35253317
doi: 10.1111/ene.15310
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2156-2161

Subventions

Organisme : Medical Research Council
ID : MR/T001712/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R01 NS072248
Pays : United States

Informations de copyright

© 2022 European Academy of Neurology.

Références

Cintra VP, Dohrn MF, Tomaselli PJ, et al. Rare mutations in ATL3, SPTLC2 and SCN9A explaining hereditary sensory neuropathy and congenital insensitivity to pain in a Brazilian cohort. J Neurol Sci. 2021;427:117498.
Davidson G, Murphy S, Polke J, et al. Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J Neurol. 2012;259(8):1673-1685.
Rotthier A, Baets J, Vriendt ED, et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain. 2009;132(Pt 10):2699-2711.
Cortese A, Simone R, Sullivan R, et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019;51(4):649-658.
Kumar KR, Cortese A, Tomlinson SE, et al. RFC1 expansions can mimic hereditary sensory neuropathy with cough and Sjogren syndrome. Brain. 2020;143(10):e82.
Malaquias MJ, Mendes Pinto C, Sardoeira A, et al. Spasmodic cough preceding CANVAS phenotype in a family with biallelic repeat expansions in RFC1. Neurol Sci. 2021;42(2):749-753.
Traschütz A, Cortese A, Reich S, et al. Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease. Neurology. 2021;96(9):e1369-e1382.
Curro R, Salvalaggio A, Tozza S, et al. RFC1 expansions are a common cause of idiopathic sensory neuropathy. Brain. 2021;144(5):1542-1550.
Gonzalez M, Falk MJ, Gai X, Postrel R, Schule R, Zuchner S. Innovative genomic collaboration using the GENESIS (GEM.app) platform. Hum Mutat. 2015;36(10):950-956.
Fazal S, Danzi MC, Cintra VP, et al. Large scale in silico characterization of repeat expansion variation in human genomes. Sci Data. 2020;7(1):294.
Fan Y, Zhang S, Yang J, et al. No biallelic intronic AAGGG repeat expansion in RFC1 was found in patients with late-onset ataxia and MSA. Parkinsonism Relat Disord. 2020;73:1-2.
Akçimen F, Ross JP, Bourassa CV, et al. Investigation of the RFC1 repeat expansion in a Canadian and a Brazilian ataxia cohort: identification of novel conformations. Front Genet. 2019;10:1219.

Auteurs

Danique Beijer (D)

Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Dr. John T. Macdonald Foundation, Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA.

Maike F Dohrn (MF)

Dr. John T. Macdonald Foundation, Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Department of Neurology, Medical Faculty RWTH Aachen University, Aachen, Germany.

Jonathan De Winter (J)

Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Neuromuscular Reference Center, Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.

Sarah Fazal (S)

Dr. John T. Macdonald Foundation, Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA.

Andrea Cortese (A)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology, London, UK.
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Tanya Stojkovic (T)

Reference Center for Neuromuscular Diseases, Neuro-myology Department, Pitié-Salpêtrière University Hospital, APHP, Paris, France.

Gorka Fernández-Eulate (G)

Reference Center for Neuromuscular Diseases, Neuro-myology Department, Pitié-Salpêtrière University Hospital, APHP, Paris, France.
Neuro-Metabolism Unit, Reference Center for Lysosomal Diseases, Neurology Department, Pitié-Salpêtrière University Hospital, APHP, Paris, France.

Gauthier Remiche (G)

Centre de Référence Neuromusculaire, Department of Neurology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Mattia Gentile (M)

Medical Genetic Unit, Department of Reproductive Pregnancy Risk, ASL BARI, Bari, Italy.

Rudy Van Coster (R)

Division of Pediatric Neurology and Metabolism, Department of Pediatrics, University Hospital Ghent, Ghent, Belgium.

Claudia Dufke (C)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
Center for Rare Diseases, University of Tuebingen, Tuebingen, Germany.

Matthis Synofzik (M)

Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

Peter De Jonghe (P)

Neuromuscular Reference Center, Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.

Stephan Züchner (S)

Dr. John T. Macdonald Foundation, Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA.

Jonathan Baets (J)

Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Neuromuscular Reference Center, Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH